| For: | Teixeira MF, Borad M, Serrano Uson Junior PL. Circulating tumor DNA in biliary tract cancers: A review of current applications. World J Clin Oncol 2025; 16(10): 107875 [PMID: 41178929 DOI: 10.5306/wjco.v16.i10.107875] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i10/107875.htm |
| Number | Citing Articles |
| 1 |
Khalil Choucair, Shadi Chamseddine, Asfar Azmi, Philip A. Philip. Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1769447
|
| 2 |
Jingnan Xue, Longhao Zhang, Kai Zhang, Yu Wu, Kai Zhou, Xin Lu. Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1697056
|
| 3 |
Haixing Wei, Jie Wang, Qing Wu, Mengbin Qin. Circulating Tumor DNA in Cholangiocarcinoma: A Precision Oncology Roadmap. Cancer Management and Research 2026; doi: 10.2147/CMAR.S574678
|
| 4 |
Nan Yao, Wenqiang Li, Ning Duan, Fuzhou Han, Guoyong Yu, Jun Qu. Practical integration of ctDNA-defined minimal residual disease in gastrointestinal cancers: testing windows and evidence-aligned management frameworks. Clinical and Translational Oncology 2026; doi: 10.1007/s12094-026-04405-6
|